These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7813708

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of scoring systems in primary myelodysplastic syndromes.
    Maschek H, Gutzmer R, Choritz H, Georgii A.
    Ann Hematol; 1995 Jun; 70(6):301-8. PubMed ID: 7632809
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Proliferative indices, cytogenetics, immunophenotye and other prognostic parameters in myelodysplastic syndromes.
    Varma N, Varma S.
    Indian J Pathol Microbiol; 2008 Jun; 51(1):97-101. PubMed ID: 18417875
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
    Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W.
    Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
    Ohshima K, Karube K, Shimazaki K, Kamma H, Suzumiya J, Hamasaki M, Kikuchi M.
    Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients].
    Rubio-Félix D, Giraldo MP, Perella M, Gimeno J, Franco E, Giralt M.
    Sangre (Barc); 1991 Dec; 36(6):463-9. PubMed ID: 1812580
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
    Shimazaki K, Ohshima K, Suzumiya J, Kawasaki C, Kikuchi M.
    Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
    Riccardi A, Giordano M, Girino M, Cazzola M, Montecucco CM, Cassano E, Danova M, Ucci G, Castello A, Coci A.
    Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832
    [Abstract] [Full Text] [Related]

  • 17. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis.
    Maschek H, Kaloutsi V, Rodriguez-Kaiser M, Werner M, Choritz H, Mainzer K, Dietzfelbinger M, Georgii A.
    Ann Hematol; 1993 Mar; 66(3):117-22. PubMed ID: 8471656
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
    Omine M, Yamauchi H.
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
    [Abstract] [Full Text] [Related]

  • 20. [Study on prognostic factors in twenty-five patients with myelodysplastic syndrome].
    Toyama T, Uno H, Yamashita K, Kubuki Y, Suzuki M, Maeda K, Matsuoka H, Tsubouchi H.
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):227-32. PubMed ID: 7857097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.